1. Arnett FC, Edworthy SM, Bloch DA, et al. (1988): The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
2.
Klareskog L, Catrina AI, Paget S (2009): Rheumatoid arthritis. Lancet 373: 659-672.
3.
Bartok B, Firestein GS (2010): Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233: 233-255.
4.
Bottini N, Firestein GS (2013): Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 9: 24-33.
5.
Noss EH, Brenner MB (2008): The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 223: 252-270.
6.
Lefevre S, Knedla A, Tennie C, et al. (2009): Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15: 1414-1420.
7.
Sena LA, Chandel NS (2012): Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48: 158-167.
8.
Lin W, Shen P, Song Y, et al. (2021): Reactive oxygen species in autoimmune cells: function, differentiation, and metabolism. Front Immunol 12: 635021.
9.
Lee HR, Yoo SJ, Kim J, et al. (2021): Reduction of oxidative stress in peripheral blood mononuclear cells attenuates the inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis. Int J Mol Sci 22: 12411.
10.
Lee HR, Yoo SJ, Kim J, et al. (2020): The effect of nicotinamide adenine dinucleotide phosphate oxidase 4 on migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 22: 116.
11.
Robson CN, Hickson ID (1991): Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res 19: 5519-5523.
12.
Ando K, Hirao S, Kabe Y, et al. (2008): A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 36 4327-4336.
13.
Xanthoudakis S, Curran T (1992): Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-665.
14.
Gaiddon C, Moorthy NC, Prives C (1999): Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J 18: 5609-5621.
15.
Lee HM, Yuk JM, Shin DM, et al. (2009): Apurinic/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses. J Immunol 183: 6839-6848.
16.
Jin SA, Seo HJ, Kim SK, et al. (2015): Elevation of the serum apurinic/apyrimidinic endonuclease 1/redox factor-1 in coronary artery disease. Korean Circ J 45: 364-371.
17.
Yoo IS, Lee YR, Kang SW, et al. (2021): Elevated APE1/Ref-1 levels of synovial fluids in patients with rheumatoid arthritis: reflection of disease activity. J Clin Med 10: 5324.
18.
Chabaud M, Garnero P, Dayer JM, et al. (2000): Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12: 1092-1099.
19.
Xu T, Ying T, Wang L, et al. (2017): A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A. Oncotarget 8: 81860-81872.
20.
Aletaha D, Neogi T, Silman AJ, et al. (2010): 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 2569-2581.
21.
Pei DS, Jia PP, Luo JJ, et al. (2019): AP endonuclease 1 (Apex1) influences brain development linking oxidative stress and DNA repair. Cell Death Dis 10: 348.
22.
Farkas DL, Wei MD, Febbroriello P, et al. (1989): Simultaneous imaging of cell and mitochondrial membrane potentials. Biophys J 56: 1053-1069.
23.
Yao H, de Boer WI, Rahman I (2008): Targeting lung inflammation: novel therapies for the treatment of COPD. Curr Respir Med Rev 4: 57-68.
24.
Hernandez-Santana YE, Giannoudaki E, Leon G, et al. (2019): Current perspectives on the interleukin-1 family as targets for inflammatory disease. Eur J Immunol 49: 1306-1320.
25.
Coulthard LR, White DE, Jones DL, et al. (2009): p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med 15: 369-379.
26.
Bartok B, Boyle DL, Liu Y, et al. (2012): PI3 kinase delta is a key regulator of synoviocyte function in rheumatoid arthritis. Am J Pathol 180: 1906-1916.
27.
Pap T, Müller-Ladner U, Gay RE, et al. (2000): Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2: 361-367.
28.
Nygaard G, Firestein GS (2020): Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol 16: 316-333.
29.
Ribbens C, Andre B, Jaspar JM, et al. (2000): Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. J Rheumatol 27: 888-893.
30.
Wan J, Zhang G, Li X, et al. (2021): Matrix metalloproteinase 3: a promoting and destabilizing factor in the pathogenesis of disease and cell differentiation. Front Physiol 12: 663978.
31.
Pucino V, Certo M, Varricchi G, et al. (2020): Metabolic checkpoints in rheumatoid arthritis. Front Physiol 11: 347.
32.
Bustamante MF, Garcia-Carbonell R, Whisenant KD et al. (2017): Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res 19: 110.
33.
Yoshitomi H (2019): Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes. Front Immunol 10: 1395.
34.
Mantha AK, Dhiman M, Taglialatela G, et al. (2012): Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: impact on APE1/Ref-1’s protein-protein interaction. J Neurosci Res 90: 1230-1239.
35.
Nishi T, Shimizu N, Hiramoto M, et al. (2002): Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J Biol Chem 277: 44548-44556.
36.
Wang X, Fan D, Cao X, et al. (2022): The role of reactive oxygen species in the rheumatoid arthritis-associated synovial microenvironment. Antioxidants (Basel) 11: 1153.
37.
Park MS, Choi S, Lee YR, et al. (2016): Secreted APE1/Ref-1 inhibits TNF-alpha-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor. Sci Rep 6: 23015.
38.
Ramos-DeSimone N, Hahn-Dantona E, Sipley J, et al. (1999): Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274: 13066-13076.
39.
Lee YK, Kim SW, Park JY, et al. (2017): Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential. Int J Nanomedicine 12: 5761-5779.
